课题基金 / 基金详情

Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement

Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement
非人灵长类动物针对 SARS-CoV-2 的疫苗功效:保护、交叉保护和免疫增强
批准号:
430657
负责人:
Falzarano Darryl
金额:
$106.31万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-05-01 至 2021-05-01

项目摘要

项目成果

Falzarano Darryl的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In December 2019 a novel coronavirus (CoV) was identified as the cause of pneumonia in a cluster of patients in Wuhan, China. This virus is related to severe acute respiratory syndrome (SARS)-CoV and has been named SARS-CoV-2. Since then (in only the last
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement
  • 批准号:
    443206
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Falzarano Darryl
  • 依托单位:
Formulation optimization and characterization of a novel combination adjuvant for pandemic preparedness
  • 批准号:
    463759
  • 项目类别:
    Operating Grants
  • 资助金额:
    $14.12万
  • 财政年份:
    2021
  • 负责人:
    Falzarano Darryl
  • 依托单位:
Animal models for SARS-CoV-2: vaccines and immune enhancement
  • 批准号:
    422763
  • 项目类别:
    Operating Grants
  • 资助金额:
    $72.83万
  • 财政年份:
    2020
  • 负责人:
    Falzarano Darryl
  • 依托单位:
Sex as a Biological Variable Supplement - Animal models for SARS-CoV-2: vaccines and immune enhancement
  • 批准号:
    424689
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2020
  • 负责人:
    Falzarano Darryl
  • 依托单位:
海外基金